Drug combination study reveals new clues to treatment resistance in deadly melanoma

Дата публикации: 23-09-2026 12:00:06

Uveal melanoma is a rare, aggressive cancer that starts inside the eye and often spreads to the liver. Few treatment options exist, and unlike some forms of skin melanoma that can respond well to modern therapies, metastatic uveal melanoma (MUM) remains difficult to treat.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	New experimental approach may help overcome drug resistance in deadly brain cancer	5	8	09-07-2026
2	Tebentafusp continues to provide long-term OS benefit in previously untreated patients with unresectable or metastatic uveal melanoma	0	14.93	21-09-2026
3	New targeted therapy shows promising early results in advanced pancreatic cancer	2	7	05-07-2026
4	New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer	5	7	02-07-2026
5	Moderna's cancer vaccine cuts melanoma recurrence risk in early trial: What we know	0	7.73	26-08-2026
6	New study reveals how blood cancers outsmart BTK-targeted therapies	0	8.1	28-07-2026
7	Scientists discover hidden “master switch” driving skin cancer growth and immune escape	0	9.62	21-04-2026
8	Malaga searches for 'switch' that halts most aggressive phase of blood cancer	0	10	13-05-2026
9	Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in First-Line Treatment of dMMR/MSI-H mCRC	0	16.8	11-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 6.46. Источник: medicalxpress.com.